Consolidated Statements of Cash Flows $ in Thousands	7 Months Ended	9 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)
Cash flows from operating activities:
Net loss	$ 0	$ (49,815)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	0	65,145
Unrealized gain on changes in fair value of financial instruments	0	(993)
Realized loss on settlement of real estate-related securities	0	177
Straight-line rent adjustment	0	(1,118)
Amortization of above- and below-market lease intangibles	0	(792)
Amortization of below-market and prepaid ground lease intangibles	0	156
Amortization of deferred financing costs	0	771
Amortization of restricted stock grants	0	77
Bad debt expense	0	709
Change in assets and liabilities:
(Increase) / decrease in other assets	0	(10,824)
Increase / (decrease) in due to affiliates	0	18,523
Increase / (decrease) in accounts payable, accrued expenses, and other liabilities	0	22,244
Net cash provided by operating activities	0	44,260
Cash flows from investing activities:
Acquisitions of real estate	0	(2,245,885)
Capital improvements to real estate	0	(3,290)
Pre-acquisition costs	0	(9,201)
Purchase of real estate-related securities	0	(660,151)
Proceeds from settlement of real estate-related securities	0	16,596
Net cash used in investing activities	0	(2,901,931)
Cash flows from financing activities:
Proceeds from issuance of common stock	0	1,264,053
Offering costs paid	0	(15,388)
Subscriptions received in advance	0	98,435
Repurchase of common stock	0	(187)
Borrowings from mortgage notes, term loan, and revolving credit facility	0	1,055,913
Borrowings under repurchase agreements	0	491,026
Settlement of repurchase agreements	0	(12,571)
Borrowings from affiliate line of credit	0	617,650
Repayments on affiliate line of credit	0	(495,150)
Payment of deferred financing costs	0	(12,384)
Contributions from non-controlling interests	0	8,978
Distributions	0	(6,203)
Net cash provided by financing activities	0	2,994,172
Net change in cash and cash equivalents and restricted cash	0	136,501
Cash and cash equivalents and restricted cash, beginning of period	200	200
Cash and cash equivalents and restricted cash, end of period	200	136,701
Reconciliation of cash and cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents	200	30,820
Restricted cash	0	105,881
Cash and cash equivalents and restricted cash, end of period	200	136,701
Non-cash investing and financing activities:
Assumption of mortgage notes in conjunction with acquisitions of real estate	0	107,369
Assumption of other liabilities in conjunction with acquisitions of real estate	0	17,093
Accrued capital expenditures and acquisition related costs	0	314
Accrued pre-acquisition costs	0	905
Accrued distributions	0	5,624
Accrued stockholder servicing fee due to affiliate	0	75,998
Accrued offering costs due to affiliate	0	7,552
Distribution reinvestment	0	13,494
Accrued deferred financing costs	$ 0	$ 307